Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wegener's granulomatosis.

Peter Lamprecht1, Wolfgang L Gross

  • 1Department of Rheumatology, University Hospital of Schleswig- Holstein, Campus Lübeck, Lübeck, Germany.

Herz
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype.

Journal of human immunity·2026
Same author

ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study.

Frontiers in immunology·2026
Same author

Role of neutrophils in regulating vascular permeability in inflammatory and autoimmune diseases.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Vasculitis management remains a challenge during pregnancy.

The Lancet. Rheumatology·2025
Same author

Antineutrophil cytoplasmic antibody-associated vasculitis: insights into relapse risk and future management directions.

Frontiers in immunology·2025
Same journal

[Advancing cardiovascular prevention : Evidence-based design of healthy and sustainable food environments].

Herz·2026
Same journal

[Effects of air pollution on cardiovascular health].

Herz·2026
Same journal

[Heart and climate].

Herz·2026
Same journal

Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

Herz·2026
Same journal

[Noise and the heart].

Herz·2026
Same journal

[The cardiovascular exposome: areas of action for prevention and practical cardiology].

Herz·2026
See all related articles

Wegener's granulomatosis involves respiratory and kidney inflammation and vasculitis. Tumor necrosis factor-alpha blockade is a potential treatment for refractory cases, suggesting a link to accelerated atherosclerosis.

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Biology

Background:

  • Wegener's granulomatosis is a severe autoimmune disease characterized by respiratory tract inflammation, glomerulonephritis, and small vessel vasculitis.
  • Proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) are highly specific markers, particularly in generalized disease.
  • Tumor necrosis factor-alpha (TNF-alpha) producing T-cells are implicated in the disease pathogenesis.

Purpose of the Study:

  • To explore the rationale for using TNF-alpha-blocking agents in refractory Wegener's granulomatosis.
  • To investigate the role of vasculitis and systemic inflammation in accelerated atherosclerosis in Wegener's granulomatosis patients.

Main Methods:

  • Review of existing studies on Wegener's granulomatosis, PR3-ANCA, T-cell populations, and TNF-alpha.

Related Experiment Videos

  • Analysis of findings related to endothelial dysfunction and arterial wall thickening in affected patients.

    • Main Results:

    • Expansion of circulating TNF-alpha-producing Th1-type CD4(+)CD28(-) T-cells supports anti-TNF-alpha therapy.
    • Vasculitis is linked to endothelial dysfunction and may be influenced by TNF-alpha.
    • Wegener's granulomatosis patients exhibit intima-media thickening and increased incidence of cardiovascular events.

    Conclusions:

    • TNF-alpha blockade is a promising therapeutic strategy for treatment-resistant Wegener's granulomatosis.
    • Systemic inflammation and vasculitis in Wegener's granulomatosis contribute to accelerated atherosclerosis, increasing cardiovascular risk.